Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Screening and evaluation of new inhibitors of hepatic glucose production
The Journal of Antibiotics, 10/07/09
Hashimoto J et al. – 4–hydro–3–methoxyacetophenone and 5–nitrosalicylaldehyde may be useful as a lead compound of anti–type 2 diabetic drugs.
Related Articles
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Relevance Score: 90%
Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population
Metabolism-Clinical and Experimental, 11/03/09
Relevance Score: 90%
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09
Relevance Score: 90%
Hepatic fat and inflammation in type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 90%
Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09
Relevance Score: 90%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


